Table 2 Comparison between the group of patients with and without cholecystitis
Parameters | With cholecystitis (n = 66) | Without cholecystitis (n = 48) | P value |
|---|---|---|---|
Age (years) | 54.14 ± 15.34 | 49.9 ± 13.97 | 0.133 |
Gender | |||
Male (%) | 55 (83.33%) | 31 (64.58%) | 0.022 |
Female (%) | 11 (16.67%) | 17 (35.42%) | |
Hospital days | 20.12 ± 9.43 | 12.98 ± 7.26 | < 0.001 |
Liver cirrhosis no. (%) | 7 (10.61%) | 1 (2.08%) | 0.079 |
Liver failure no. (%) | 12 (18.18%) | 6 (12.50%) | 0.411 |
Death no. (%) | 5 (7.58%) | 1 (2.08%) | 0.195 |
Spontaneous peritonitis no. (%) | 6 (9.09%) | 0 (0%) | 0.032 |
Upper gastrointestinal hemorrhage no. (%) | 2 (3.03%) | 1 (2.08%) | 0.755 |
Hepatic encephalopathy no. (%) | 1 (1.52%) | 1 (2.08%) | 0.820 |
Hepatorenal syndrome no. (%) | 2 (3.03%) | 0 (0%) | 0.224 |
ALB (g/L) | 30.58 ± 4.79 | 35.65 ± 4.27 | < 0.001 |
TBA (µmol/L) | 171.66 ± 141.74 | 83.37 ± 94.02 | < 0.001 |
TB (µmol/L) | 241.31 ± 136.67 | 102.07 ± 87.47 | < 0.001 |
DB (µmol/L) | 204.12 ± 122.47 | 82.54 ± 76.72 | < 0.001 |
ALT (U/L) | 1670.84 ± 1297.83 | 1614.60 ± 1716.71 | 0.842 |
AST (U/L) | 1290.40 ± 1138.70 | 1151.55 ± 1536.80 | 0.580 |
ALP (U/L) | 213.02 ± 79.89 | 194.20 ± 97.37 | 0.26 |
GGT (U/L) | 268.60 ± 274.15 | 286.76 ± 245.50 | 0.716 |
LDH (U/L) | 710.05 ± 716.46 | 613.07 ± 558.51 | 0.448 |
CHE (U/L) | 3836.86 ± 1426.02 | 5674.67 ± 2088.57 | < 0.001 |
BUN (µmol/L) | 6.66 ± 6.19 | 5.17 ± 1.69 | 0.112 |
Cr (µmol/L) | 80.78 ± 55.79 | 71.57 ± 24.13 | 0.291 |
PTA (%) | 74.72 ± 24.51 | 88.87 ± 25.46 | 0.003 |
TC (mmol/L) | 3.57 ± 1.11 | 4.43 ± 1.86 | 0.037 |
TG (mmol/L) | 2.45 ± 1.37 | 1.69 ± 0.97 | 0.030 |
LDL (mmol/L) | 1.45 ± 0.98 | 2.45 ± 1.29 | 0.002 |
WBC (× 1012/L) | 5.29 ± 2.15 | 4.88 ± 1.61 | 0.270 |
N (%) | 63.54 ± 10.59 | 58.19 ± 12.06 | 0.013 |